ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives

RECENT NEWS

ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results

2026-08-07

READ MORE >

ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

2026-07-24

READ MORE >

NASDAQ - ANIP

$78.43

+ 1.56 (2.03%)

Pricing delayed by 20 minutes
Last updated 2026-08-19 10:21:00